NASDAQ: IRTC · Industrial Applications and Services · 6 alerts · CIK 1388658
Share price
$90.83Close, Nov 16
Market cap
$3.05B
Shares outstanding
33.62MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All iRhythm Holdings, Inc. filings on SEC EDGAR ↗
iRhythm Holdings adopted a new nonqualified Deferred Compensation Plan effective January 1, 2027, for eligible employees and non-employee directors. The plan allows participants, including named executive officers, to defer up to 80% of base salary and 100% of annual bonuses or cash fees into notionally invested accounts. While the plan is unfunded, the company intends to establish a trust to hold assets for these future obligations.
iRhythm Holdings' board of directors has authorized a new share repurchase program to buy back up to $200 million of its outstanding common stock. The company plans to fund the repurchases using existing cash and cash equivalents and ongoing cash from operations. The authorization reflects management's confidence in the core business and growth opportunities following the recent acquisition of VitalConnect.
For the nine months ended September 30, 2026, iRhythm reported revenue of $645.2 million, a 19.9% increase over the prior year, though it incurred a net loss from operations of $51.3 million. Financial results were significantly impacted by $63.7 million in litigation settlements and an acquisition of Vital Connect, Inc. mentioned in forward-looking statements.
iRhythm Holdings reported Q3 2026 revenue of $221.6 million, a 14.9% year-over-year increase driven by strong volume demand for its Zio Monitor. The company also announced the completion of its acquisition of VitalConnect on October 5, 2026, and the closing of a new $300 million revolving credit facility.
Term
Q3 2026
“Our third quarter results reflect the continued strength of our core business. Demand for Zio Monitor remains robust, exceeding our expectations in the quarter, driven by volume growth across care settings and channels. We also continued to take meaningful steps forward with significant margin expansion, and consistent execution against our strategic priorities.”
Quentin Blackford, President and Chief Executive Officer